Purchase Order 15B10926P00000014
- Not listed
- McKesson Corporation received a purchase order award from the Federal Medical Center Lexington on September 1, 2025, for multiple medication shipments to be used during the first quarter of fiscal year 2025 (September 1-30, 2025). The contract is a firm fixed-price purchase order with a ceiling value of $12,790.94 and no set-aside designation. Performance will be completed at McKesson's Irving, Texas location, with a completion date of September 30, 2025. This award represents a continuation...
- McKesson Corporation was awarded a firm fixed-price purchase order valued at $20,796.88 by the Federal Medical Center Lexington to supply multiple invoices for medication shipments during fiscal year 2026, specifically for the period of October 1–31, 2025. The contract is not set-aside and represents routine pharmaceutical procurement for the federal correctional facility. Performance will take place in Irving, Texas, where McKesson maintains its primary distribution operations. This award...
- The Department of Justice Bureau of Prisons Federal Medical Center in Lexington awarded McKesson Corporation a $17,956.85 purchase order to supply medications. Under the terms of the non-contract award, McKesson will ship medications to the correctional facility in Irving, Texas between September 1st and October 23rd, 2023. As the largest pharmaceutical distributor in the U.S., McKesson will fulfill this requirement from their distribution center in Irving. No subcontractors or set-aside...
- McKesson Corporation, a major pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, was awarded a firm fixed-price purchase order by the Federal Medical Center Lexington on December 1, 2025, for $19,749.70. The contract covers the provision of Medication-Assisted Treatment (MAT) medications—both controlled and non-controlled—for the period from January 1 through December 31, 2026, under McKesson's existing account numbers 077960 and 677508. The award was...
- The U.S. Federal Medical Center Lexington, a civilian facility within the Department of Justice, awarded a delivery order to McKesson Corporation for routine wholesale medication purchases valued at $610.7K. This Firm Fixed Price contract covers multiple invoices for controlled and non-controlled pharmaceutical shipments received during the first quarter of fiscal year 2025 (September 1-30, 2025). The contract was awarded without a set-aside designation, reflecting McKesson's status as a large...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $287,645.47 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from November 1, 2022 through December 9, 2022. Mckesson will supply pharmaceutical products to the Federal Medical Center Lexington facility located in...
- The U.S. Federal Medical Center Lexington awarded a delivery order to McKesson Corporation for routine wholesale medication purchases totaling $557,208.30 through October 31, 2025. This firm fixed-price contract covers multiple invoices for controlled and non-controlled pharmaceutical shipments received during October 2025. The contract represents a non-competed award with no set-aside designation, with performance fulfilled from McKesson's Irving, Texas distribution facility. Federal Medical...
- McKesson Corporation received a $650,000.53 delivery order award from the Federal Medical Center Lexington for non-controlled and controlled substances and routine wholesale medication purchases. The contract, issued on November 1, 2025, with an ultimate completion date of November 30, 2025, covers multiple invoices for medication shipments received during the first 30 days of November 2025. This firm fixed-price delivery order represents routine pharmaceutical procurement to support the medical...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $369,576.55 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases from January 1, 2022 through March 31, 2022. Mckesson will supply pharmaceutical products to the Federal Medical Center Lexington facility located in Irving, Texas from its distribution center in the same city. No...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded McKesson Corporation, doing business as McKesson Drug Company, a $167,305.48 firm fixed price delivery order contract to provide routine wholesale non-controlled and controlled substance medication purchases from October through December 2023. McKesson, a wholly owned subsidiary of McKesson Corporation, will fulfill multiple invoices for medication shipments from its location in Irving, Texas to the Bureau of...
McKesson Corporation, a leading pharmaceutical distribution and medical supply provider headquartered in Irving, Texas, received a $17,953.48 firm fixed-price purchase order from the Federal Medical Center Lexington on December 1, 2025, for multiple medication shipments to be delivered through December 31, 2025. This non-competitive contract award addresses the medical center's pharmaceutical supply needs for the final month of fiscal year 2026. The award was made without a set-aside designation, reflecting McKesson's status as a large business contractor. The place of performance is McKesson's distribution facility in Irving, Texas. The Federal Medical Center Lexington, a civilian medical facility operated by the Bureau of Prisons under the Department of Justice, regularly procures controlled and non-controlled medications through established vendors. This purchase order represents routine pharmaceutical procurement for institutional healthcare operations. McKesson has established itself as a critical supplier to Bureau of Prisons facilities and other federal healthcare agencies through its extensive portfolio of federal contracts, including a $25.5 million Blanket Purchase Agreement with the Department of Homeland Security's Customs and Border Protection for medical and surgical supplies. The relatively modest ceiling value of this particular award reflects the specific medication requirements for a single month of operations at the medical center.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 12/5/25 |